Page last updated: 2024-10-30

mesalamine and Skin Diseases

mesalamine has been researched along with Skin Diseases in 5 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.

Research Excerpts

ExcerptRelevanceReference
" Mesalazine suppository was given to her for about 4 months, and glutamine capsules for 2 months, but the rectal ulcer remained unhealed."4.12Platelet-rich plasma for the treatment of chronic rectal ulcer: A case report. ( Ge, D; Li, P; Li, Y; Liu, G; Liu, J; Liu, Z; Wang, H; Wang, L; Zhao, G, 2022)
"She was diagnosed with cutaneous polyarteritis nodosa (PAN) associated with CD."1.35Cutaneous polyarteritis nodosa in a patient with Crohn's disease. ( Kinoshita, K; Komatsuda, A; Maki, N; Masai, R; Niitsu, H; Ohtani, S; Sageshima, M; Sawada, K; Togashi, M; Wakui, H, 2008)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Liu, G1
Li, Y2
Wang, L1
Li, P1
Liu, Z1
Liu, J1
Ge, D1
Zhao, G1
Wang, H1
Komatsuda, A1
Kinoshita, K1
Togashi, M1
Maki, N1
Masai, R1
Niitsu, H1
Ohtani, S1
Sageshima, M1
Sawada, K1
Wakui, H1
Akbal, E1
Koçak, E1
Köklü, S1
Caprilli, R1
Gassull, MA1
Escher, JC1
Moser, G1
Munkholm, P1
Forbes, A1
Hommes, DW1
Lochs, H1
Angelucci, E1
Cocco, A1
Vucelic, B1
Hildebrand, H1
Kolacek, S1
Riis, L1
Lukas, M1
de Franchis, R1
Hamilton, M1
Jantschek, G1
Michetti, P1
O'Morain, C1
Anwar, MM1
Freitas, JL1
Mouzas, IA1
Baert, F1
Mitchell, R1
Hawkey, CJ1
Bamba, T1
Nishiyama, Y1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Synbiotic Treatment in Crohn's Disease Patients[NCT00305409]50 participants (Anticipated)Interventional2006-06-30Completed
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392]181 participants (Anticipated)Interventional2020-07-28Recruiting
A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391]100 participants (Anticipated)Interventional2009-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for mesalamine and Skin Diseases

ArticleYear
[Clinical features and management of the elderly patients with ulcerative colitis].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:11

    Topics: Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative;

1999

Other Studies

4 other studies available for mesalamine and Skin Diseases

ArticleYear
Platelet-rich plasma for the treatment of chronic rectal ulcer: A case report.
    Medicine, 2022, Oct-14, Volume: 101, Issue:41

    Topics: Capsules; Colonic Diseases; Female; Glutamine; Humans; Mesalamine; Platelet-Rich Plasma; Rectal Dise

2022
Cutaneous polyarteritis nodosa in a patient with Crohn's disease.
    Modern rheumatology, 2008, Volume: 18, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Glucocort

2008
Mesalamine (pentasa)-induced painful skin lesions.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Mesalamine; Prognosis

2010
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006